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ABSTRACT
Background. Gulf War veterans have a number of health complaints. We therefore decided to carry
out a systematic review to identify and summarize the ﬁndings from studies that have assessed
multi-symptom conditions in Gulf War veterans and in an unexposed comparison group.
Method. Studies published between January 1990 and May 2004 were identiﬁed by searching a
large number of electronic databases. Reference lists and websites were also searched and key
researchers were contacted. Studies were included if they compared the prevalence of chronic fatigue
syndrome, multiple chemical sensitivity, CDC-deﬁned chronic multi-symptom illness, ﬁbromyalgia,
or symptoms of either fatigue or numbness and tingling in Gulf War veterans and non-Gulf
veterans. A total of 2401 abstracts were independently reviewed by two authors.
Results. Twenty-three publications fulﬁlled the inclusion criteria. Gulf deployment was most
strongly associated with chronic fatigue syndrome (OR 3.8, 95% CI 2.2–6.7). Gulf War veterans
were also approximately three and a half times more likely than non-Gulf veterans to report
multiple chemical sensitivity or chronic multi-symptom illness as deﬁned by CDC. The method-
ological quality of the studies varied but the later and larger studies were of a high methodological
standard with robust sampling strategies, adequate response rates and good adjustment for
confounders.
Conclusions. The results support the hypothesis that deployment to the Gulf War is associated with
greater reporting of multi-symptom conditions.
INTRODUCTION
Ever since the end of the Gulf War in 1991, its
veterans have expressed concern over a number
of health complaints. Symptoms that have been
reported by Gulf War veterans include sleep
problems, headache, lack of concentration,
muscle stiﬀness and stomach upsets. This has
led to the investigation of whether a speciﬁc
‘Gulf War Syndrome’ exists (Haley et al. 1997;
Ismail et al. 1999). These are common symp-
toms that often lead to presentation in primary
care and hospital settings (Kroenke & Price,
1993). As a result, many medical specialities
have developed and deﬁned various multi-
symptom syndromes that are medically un-
explained. These include chronic fatigue
syndrome, ﬁbromyalgia and multiple chemical
sensitivity (Wessely et al. 1999). There is still
controversy over the nosological status of these
syndromes, but the existence of agreed case-
deﬁnitions and the associated literature allows
for empirical study.
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The measurement of associations between
deployment to the Gulf War and later symp-
tomatology is hampered by the necessary
reliance on self-report. All measurements of
health outcomes are also prone to random error.
However, such outcomes, which are diﬃcult
to quantify objectively, might be particularly
prone both to random measurement error and
more importantly to measurement or reporting
bias. There have been a number of suggestions
that physical exposures such as multiple vacci-
nations, depleted uranium and oil ﬁres might
have caused illness in Gulf War veterans. This
study has not focused on this question because
most research into illness in Gulf War veterans
began some years after the conﬂict ended and
so it was diﬃcult to establish exposure data
without introducing bias.
This paper aims to identify and summarize
the ﬁndings from studies that have compared
the prevalence of chronic fatigue syndrome,
multiple chemical sensitivity, Centers for
Disease Control and Prevention (CDC)-deﬁned
chronic multi-symptom illness, ﬁbromyalgia or
the speciﬁc individual symptoms of fatigue
and numbness in Gulf War veterans and an
unexposed comparison group. We further aimed
to critically assess the methodological quality of
the individual studies. We have chosen to carry
out a systematic review because of the advan-
tages of this methodology in reducing bias and
aiding interpretation of the ﬁndings (Lewis et al.
1997).
METHOD
Searching
The methods employed in the systematic review
have been described in detail in another paper
(Stimpson et al. 2003) and are merely summar-
ized here. In total, 5387 studies from the period
January 1990 to May 2001 were identiﬁed for
possible inclusion by searching through data-
bases (including EMBASE, Medline, ASSIA,
SIGLE, PsycINFO, CancerLit and HealthStar,
Current Contents, CINAHL and Biological
Abstracts) and websites and by contacting
researchers in the ﬁeld. Studies were eligible
for inclusion if they contained data on military,
medical or peace-keeping personnel who were
deployed to the Gulf War together with a com-
parison group which diﬀered in its level of
exposure. Abstracts of 2296 references that re-
mained eligible were examined by two members
of the research team. Studies were excluded
if they measured simulated exposures, if they
measured non-health-related outcomes or if the
subjects were inhabitants of the Persian Gulf
rather than deployed military personnel.
All identiﬁed papers that fulﬁlled the pre-
stated inclusion criteria were categorized by
health outcome. Fifty-six studies entered the
category of symptomatology. Since the task
of systematically reviewing the association
between any symptom and any exposure would
be too great and would not provide a digestible
summary, we decided to focus on a limited
number of important outcomes. These speci-
ﬁc outcomes were chronic fatigue syndrome,
multiple chemical sensitivity, CDC-deﬁned
chronic multi-symptom illness, ﬁbromyalgia,
or symptoms of either fatigue or numbness
and tingling. Eighteen of the 56 papers did
not include any of these outcomes. We further
excluded those references that only compared
exposure histories between Gulf War veterans
(n=8), and studies which either presented
data as a factor analysis or which included
an inappropriate control group for the purposes
of this review, e.g. comparison of ill Gulf
War veterans and healthy community controls
(n=14).
An updated search of the literature from
January 2001 to May 2004 was completed which
identiﬁed 538 references. Of databases searched
in 2001, CancerLit and HealthStar are now
incorporated into Medline and Dissertation
Abstracts & Health and Psychosocial Instru-
ments are not available. Two databases not
searched in 2001, the Web of Knowledge Data-
bases, Science Citation Index and Social Science
Citation Index were included in this updated
search. Of 538 potentially relevant references,
105 were selected from the abstract (or title if
no abstract) that could be research studies with
a comparison group. Seven papers that fulﬁlled
the inclusion criteria and which contained data
relating to the speciﬁed outcomes were ident-
iﬁed. Therefore this review summarizes the ﬁnd-
ings from 23 references which compared Gulf
War veterans with non-Gulf veterans (Sutker
et al. 1993; Iowa Persian Gulf Study Group,
1997; Bell et al. 1998; Fukuda et al. 1998; Goss
Gilroy Inc., 1998; Proctor et al. 1998, 2001,
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Table 1. Characteristics of studies that have investigated the association between deployment to the Gulf War and multi-symptom
conditions amongst veterans
First-named author Study design Sample Study period Ascertainment Confounding
Sutker, 1993 Questionnaire
administered
by VA staﬀ
215 GWV 4–10 months after return from
Operation Desert Shield/Storm
70% GWV (306 eligible)
44 NGV Number of eligible NGVs
unclearSampled from 5 National
Guard and Army Reserve units
as part of debrieﬁng programme
Iowa Group, 1997,
(Black, 2000),
(Doebbeling, 2000)
Cross-sectional
telephone
interview survey
1896 GWV Sept. 1995–May 1996 78.3% GWV (2421 eligible Analysis accounted for
sampling design1799 NGV 73% NGV (2465 eligible)
DoD Manpower Data Center
used to create a stratiﬁed random
sample from 28968 military
personnel from Iowa
Those who were regulars,
enlisted, navy or coast guard,
aged up to 25 years and black
or other ethnic background
less likely to participate
Bell, 1998 Cross-sectional
telephone survey
24 GWV Autumn 1996–Spring 1997 759 GWV eligible
17 NGV 1756 NGV eligible
Random sample of 100 veterans
enrolled at Tucson VA medical
center
86% GWV (24/28)
3% of total eligible
85% NGV (17/20)
1% of total eligible
Fukuda, 1998 Cross-sectional survey 1163 GWV Jan.–Mar. 1995 6151 eligible
2560 NGV Unit response rate 35–73%
Sampled from 2 Air National
Guard units Pennsylvania, 1 Air
Force Reserve unit Florida,
1 active duty air force unit
Florida
Goss Gilroy, 1998 Cross-sectional survey 3113 Canadian GWV June–Sept. 1997 73.0% GWV (4262 eligible) NGVs matched on sex, age
group and regular/reserve
status
3439 Canadian NGV 60.3% NGV (5699 eligible)
Sampled from Department of
National Defence human
resources data ﬁles
Proctor, 1998 Cohort study 220 GWV from Fort Devens Spring 1994–Autumn 1996 51% Fort Devens
(353 sampled, 2949 eligible)
Analysis accounted for
sampling design73 GWV from New Orleans
38% New Orleans
(194 sampled, 928 eligible)
50 Germany deployed veterans
51% Germany deployed
Proctor, 2001 As Proctor, 1998 180 GWV (Fort Devens) As Proctor, 1998 As Proctor, 1998 As Proctor, 1998
46 Germany deployed veterans
[continues overleaf
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Table 1 (cont.)
First-named author Study design Sample Study period Ascertainment Confounding
Gray, 1999 Cross-sectional survey 527 GWV Sept. 1994–June 1995 Total eligible unknown
970 NGV Unit response rate 26–71%
All active-duty Seabees who
remained in service after ODS
and were serving in 1 of 2 large
Seabee Centres (California,
Mississippi)
Ishoy, 1999,
(Proctor, 2003)
Cross-sectional survey 686 GWV Feb. 1997–Jan. 1998 83.6% GWV (821 eligible) Controls matched for gender,
age and profession231 NGV
Feb.–Dec. 1999
57.8% NGV (400 sampled)
Selected from Danish Armed
Forces personnel database.
75% response
Proctor (2003) used subset of
original study:
143 GWV
72 NGV
Unwin, 1999,
(Reid, 2001)
Cross-sectional
postal survey
2735 GWV Aug. 1997–Nov. 1998 70.4% GWV (4250 eligible) Sample was stratiﬁed by service,
status, sex, age, rank and ﬁtness2393 Bosnia veterans 61.9% Bosnia (4250 eligible)
2422 Era controls 62.9% Era (4246 eligible)
Random sample taken from the
UK MoD database
Unwin: servicemen only
Reid: servicemen and women
Unwin, 2002 As Unwin, 1999 236 GWV As Unwin, 1999 74.0% GWV As Unwin, 1999
217 Bosnia veterans 70.2% Bosnia
192 Era controls 69.6% Era
Servicewomen only
Hotopf, 2003 As Unwin, 1999 1089 GWV 4-year follow-up (2001) 71.7% GWV As Unwin, 1999.
638 Bosnia veterans 66.2% Bosnia Follow-up sample stratiﬁed by
baseline fatigue643 Era controls 58.4% Era
Non-responders to follow-up
were more likely to be male,
younger, unmarried and report
poorer physical health at baseline
Kang, 2000,
(Kang, 2003)
Population-based
survey
11441 GWV 1995–1997 76.3% GWV (15000 eligible) Analysis accounted for
sampling design9476 NGV 63 2% NGV (15000 eligible)
Stratiﬁed random sample taken
from the DoD Manpower Data
Center
Non-responders were more
likely to be younger, unmarried,
non-white and enlisted
Steele, 2000 Population-based
telephone survey
1548 GWV Feb.–Aug. 1998 65% response (3138 eligible)
482 NGV Overall, Gulf and female
veterans were more likely
to respond
DoD Manpower Data Center
used to create a stratiﬁed random
sample from 16566 military
personnel from Kansas
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2003; Gray et al. 1999; Ishoy et al. 1999; Unwin
et al. 1999; Black et al. 2000; Doebbeling et al.
2000; Kang et al. 2000, 2003; Steele, 2000;
Cherry et al. 2001; Reid et al. 2001; White et al.
2001; Gray et al. 2002; Unwin et al. 2002;
Hotopf et al. 2003; Simmons et al. 2004). These
non-Gulf veterans may or may not have been
deployed elsewhere on active duty.
Data extraction
Data relating to the studies’ main hypotheses
and to methodological quality were extracted
independently by two members of the research
team onto pre-designed data extraction forms.
Some studies did not provide suﬃcient data to
provide odds ratios (ORs) that were used as
our outcome measure. Information on method-
ological quality of the individual studies in-
cluded the statistical power, the potential of
selection bias in the sampling of subjects and
in the response rate, the potential bias in the
measurement of outcomes, and the availability
of data on confounders and the controlling
for such variables in each study. We did not
summarize the quality by creating a score as
this approach has been criticized as giving equal
weight to diﬀerent aspects of methodology and
relying heavily upon the quality of reporting
rather than the quality of the original study
(Juni et al. 2001).
Statistical analysis
A summary OR was calculated with a random-
eﬀects model using the DerSimonian & Laird
method (1986). The estimate of heterogeneity
between studies was taken from the inverse
variance ﬁxed-eﬀects model. All analyses were
performed using the ‘metan’ (Bradburn et al.
1998) command in STATA version 6 (Stata
Corporation, College Station, TX, USA).
We chose to use this approach because of
our a priori view that the studies were inherently
heterogeneous. Using a ratio measure should
reduce the heterogeneity resulting from diﬀerent
thresholds of case-deﬁnitions. A random-eﬀects
model assumes that the studies in a meta-
analysis are randomly sampled from a distri-
bution of eﬀect sizes so the procedure estimates
the mean of this distribution. In contrast, a
ﬁxed-eﬀects model assumes that all the studies
are sampled from a population with a singleC
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eﬀect size which all studies are estimating. There
was insuﬃcient data to further investigate
heterogeneity.
RESULTS
We identiﬁed 23 references to 14 primary study
samples which compared the prevalence of
multi-symptom conditions in both Gulf War
veterans and non-Gulf veterans. Black et al.
(2000) and Doebbeling et al. (2000) utilized the
sample described in the Iowa study (Iowa
Persian Gulf Study Group, 1997) ; the study
sample described by Proctor et al. (2001) and
White et al. (2001) was a smaller subset of that
described by Proctor et al. (1998) ; the sample
initially described by Unwin et al. (1999; service-
men only) was later utilized by Reid et al. (2001;
servicemen and women), Unwin et al. (2002;
servicewomen only) and Hotopf et al. (2003;
4-year follow-up study) ; Kang et al. reported
data on the same study sample both in 2000
and in 2003. Although both publications by
Gray et al. (1999, 2002) included a sample of
active-duty Seabees, these were separate studies
with diﬀerent sampling strategies and ﬁeldwork
dates.
Table 1 summarizes the methodology used
in creating these 14 study samples. Nine samples
consisted of American Gulf War veterans, three
samples included British veterans, one sample
included Canadian veterans and one sample
included Danish veterans involved in UN
peacekeeping and humanitarian operations.
Sutker et al. (1993) were the only authors to
assess multi-symptom conditions soon after
returning from the war arena. All other studies
assessed these conditions from 1994 onwards.
All studies relied on self-reported measurement
of symptoms. Three studies investigated the
test–retest reliability of their measures. The
Iowa Group (1997) reported kappas between
0.35 and 0.79. Gray et al. (1999) retested a sub-
sample of subjects between 5 and 9 months later
and reported kappas varying between 0.01 and
0.86. Gray et al. (2002) also tested the reliability
of self-reported physician-diagnosed medical
conditions in 519 subjects retested 6 months
apart and reported a kappa of 0.6. These studies
cannot investigate the issue of bias and their
measure of reliability will be underestimates
as symptoms may also have changed in the
intervening period.
Table 2 summarizes the results of the 10
references that investigated the association
between Gulf deployment and chronic fatigue.
There was variation in the length of period
prevalence estimated and in the diagnosis of
chronic fatigue. Data from seven of the refer-
ences were entered into the meta-analysis. The
summary OR reﬂected a statistically signiﬁcant
association between deployment to the Gulf
War and subsequent reporting of chronic fatigue
[OR 3.81, 95% conﬁdence interval (CI) 2.17–
6.71]. The test for heterogeneity was statistically
signiﬁcant (p<0.001).
We identiﬁed 16 references (Table 3) that
investigated the association between Gulf de-
ployment and symptoms of fatigue. Cherry et al.
(2001), White et al. (2001) and Proctor et al.
(2003) did not quote prevalence estimates of
symptoms, therefore their data cannot provide
ORs. Only the study by Sutker et al. (1993)
carried out within 10 months of returning from
the war reported a non-signiﬁcant increase in
reporting of fatigue, although the CI was wide
(OR 1.98, 95% CI 0.73–5.38). All other studies
(Fukuda et al. 1998; Gray et al. 1999; Ishoy
et al. 1999; Unwin et al. 1999, 2002; Doebbeling
et al. 2000; Kang et al. 2000; Steele, 2000;
Proctor et al. 2001; Gray et al. 2002; Hotopf
et al. 2003; Simmons et al. 2004) reported a
statistically signiﬁcant association between de-
ployment and symptoms of fatigue. This was
summarized by an OR of 3.74 (95% CI
2.94–4.75) when 12 studies were entered into a
meta-analysis using a random-eﬀects model.
The test for heterogeneity based on the ﬁxed-
eﬀects model was statistically signiﬁcant
(x2=59.4, df=6, p<0.001), probably due to the
diﬀerence in eﬀect sizes demonstrated between
Unwin et al. (1999), Kang et al. (2000) and Gray
et al. (2002). It was striking that the prevalence
of self-reported fatigue was very high amongst
British Gulf war veterans, Bosnia veterans and
era controls in the study by Unwin et al. (1999,
2002). Hotopf et al. (2003) demonstrated that
4 years later the Gulf War veterans continued
to report more fatigue than the comparison
military cohorts. This seemed to be largely
explained by greater persistence of fatigue
symptoms amongst Gulf veterans, but there was
also some evidence of higher incidence of fatigue
740 H. V. Thomas et al.
in the two deployed groups when compared to
the era controls.
Seven references investigated the association
between deployment to the Gulf and multiple
chemical sensitivity, ﬁve of which provided
data for the meta-analysis with the study by
Black et al. (2000) and Gray et al. (2002) pro-
viding approximately 65% of the weight to
the summary OR (Table 4). The prevalence
estimates quoted by Bell et al. (1998) were
much higher than those reported in the other
studies probably due to the much broader
Table 2. Studies that have investigated the association between deployment to the Gulf War
and chronic fatigue syndrome amongst veterans
First-named
author Outcome deﬁnition Prevalence
OR (95% CI) in
relation to Gulf
deployment
% weight in
meta-analysis
Iowa Group,
1997
Centers for Disease Control and
Prevention (CDC) Chronic
Fatigue Syndrome
Questionnaire and Chalder
et al.’s (1993) Fatigue Scale.
Regular military 3.15 (1.60–6.20) 15.0
GWV prevalence 1.0%
NGV prevalence 0.2%
Prevalence 1 month prior to interview
National Guard/Reserves
GWV prevalence 2
.
9%
NGV prevalence 1
.
1%
Goss Gilroy,
1998
CDC Chronic Fatigue
Syndrome Questionnaire.
OR chronic fatigue
Period of prevalence is unclear
5.27 (95% CI 3.95–7.03)
Unwin, 1999 Chalder et al.’s Fatigue Scale. GWV prevalence 3.3%
Bosnia prevalence 0.8%Prevalence 1 month prior to interview
Era prevalence 0.8%
Reid, 2001 CDC diagnosis derived from
Chalder et al.’s Fatigue Scale
and SF-36.
GWV prevalence 2.1% 1.17 (0.81–1.69) 17.7
Prevalence 1 month prior to interview
Bosnia prevalence 0
.
7%
Era prevalence 1.8%
Unwin, 2002 Chalder et al.’s Fatigue Scale. GWV prevalence 4.7%
Prevalence 1 month prior to interview Bosnia prevalence 0.5%
Era prevalence 0
.
5%
Steele, 2000 CDC diagnosis derived from
self-reported symptoms and
fatigue characteristics.
GWV prevalence 7.1% 11.04 (3.49–34.93) 10.7
Prevalence 1 year prior to interview
NGV prevalence 0.7%
Proctor, 2001 CDC diagnosis derived from
self-reported symptoms.
GWV prevalence 7.5%
(excluding rule-out
indicators 2.0%)
2.37 (0.13–44.83) 3.1
Unknown prevalence period
Germany deployed
prevalence 0%
Gray, 2002 Self-reported physician
diagnosis of chronic fatigue
syndrome, onset after Aug. 1991
GWV prevalence 5.17% 6.75 (4.77–9.54) 17.9
Deployed elsewhere
prevalence 0.79%
Non-deployed prevalence
0.68%
Kang, 2003 CDC diagnosis derived from
self-reported symptoms.
GWV prevalence 5.6% 4.87 (5.96–21.92) 18.7
Prevalence 1 year and 1 month
prior to interview
NGV prevalence 1.2%
Simmons,
2004
Prevalence of self-reported chronic
fatigue syndrome since 1990
GWV 0.4% 3.5 (2.1–5.5) 16.9
NGV 0.1%
Summary OR 3.81 (2.17–6.71)
Heterogeneity x2=59.4, df=6, p<0.0001
GWV, Gulf War veterans; NGV, non-Gulf veterans.
OR, Odds ratio with conﬁdence intervals in parentheses. Summary OR derived from random-eﬀects model.
Iowa study combines prevalence in regular military and National Guard/Reserves for meta-analysis.
Goss Gilroy not used in meta-analysis since raw numbers not provided. Unwin data not used in meta-analysis to avoid duplication with
Reid data. Reid study compares Gulf versus era controls for meta-analysis. Proctor study uses prevalence excluding rule-out indicators for
meta-analysis. Gray study compares Gulf versus controls deployed elsewhere for meta-analysis.
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deﬁnition of the outcome. Overall, the odds of
reporting multiple chemical sensitivity was
approximately three and a half times greater
amongst veterans deployed to the Gulf War
(OR 3.56, 95% CI 2.03–6.24). The test for
heterogeneity was of borderline statistical sig-
niﬁcance (p=0.05).
All ﬁve studies that investigated chronic
multi-symptom illness used the CDC diagnosis
(Table 5). Prevalence estimates varied greatly
Table 3. Studies that have investigated the association between deployment to the Gulf War
and symptoms of fatigue amongst veterans
First-named
author Outcome deﬁnition Prevalence
OR in relation to
Gulf deployment
% weight in
meta-analysis
Sutker, 1993 Current fatigue/lack of energy GWV prevalence 20% 1.98 (0.73–5.38) 3.7
NGV prevalence 11%
Fukuda, 1998 Current fatigue GWV prevalence 43% 3.69 (3.16–4.31) 9.9
NGV prevalence 17%
Gray, 1999 Unusual fatigue GWV prevalence 20.1% 4.44 (3.13–6.32) 8.5
o1 month since July 1990 NGV prevalence 5.4%
Ishoy, 1999 Abnormal feeling of fatigue
during preceding 12 months
Symptom after Aug. 1990 2.95 (1.89–4.62) 7.6
GWV prevalence 26.4%
NGV prevalence 10.8%
Symptom before Aug. 1990
GWV prevalence 1.9%
NGV prevalence 1.7%
Unwin, 1999 Current fatigue (past month) GWV prevalence 50.7% 2.68 (2.40–3.00) 10.1
Bosnia prevalence 26.3%
Era prevalence 27.7%
Unwin, 2002 Current fatigue (past month) GWV prevalence 59.4% 1.9 (1.1–3.2) 8.1
Bosnia prevalence 31.6%
Era prevalence 34.7%
Hotopf, 2003 Current fatigue GWV prevalence 43.4%
Bosnia prevalence 32.7%
Era prevalence 22.0%
Doebbeling, 2000 Period of extreme fatigue
every day or almost every
day in past year
GWV prevalence 23% 3.02 (2.49–3.66) 9.7
NGV prevalence 9%
Kang, 2000 Fatigue GWV prevalence 38% 3.47 (3.25–3.72) 10.3
Period of prevalence unclear NGV prevalence 15%
Steele, 2000 Period of fatigue in past year GWV prevalence 36% 4.14 (3.01–5.68) 8.7
NGV prevalence 12%
Proctor, 2001 Current fatigue not meeting
CDC diagnosis
GWV prevalence 29.4% 4.38 (1.50–12.83) 3.4
Germany deployed prevalence 8.7%
Cherry, 2001 Tiredness (past month) GWV mean score=8.3
Visual analogue scale NGV mean score=5.0
Gray, 2002 Unusual fatigue in past year GWV prevalence 38.95% 3.87 (3.50–4.29) 10.1
Deployed elsewhere prevalence 14.13%
Non-deployed prevalence 13.43%
White, 2001 Proﬁle of Mood States GWV t score 47.4, S.E.=0.62
NGV t score 42.1, S.E.=0.84
Diﬀerence p=0.001
Simmons, 2004 Self-reported general fatigue GWV prevalence 10.8% 9.6 (8.3–11.1) 10.0
NGV prevalence 1.2%
Proctor, 2003 Proﬁle of Mood States
(Raw scores)
GWV 6.3, S.E.=0.4
NGV 4.6, S.E.=0.5
Diﬀerence p=0.005
Summary OR 3.74 (2.94–4.75)
Heterogeneity x2=241.8, df=11, p<0.0001
GWV, Gulf War veterans; NGV, non-Gulf veterans.
OR, Odds ratio with conﬁdence intervals in parentheses. Summary OR derived from random-eﬀects model.
Unwin studies compare Gulf versus era controls for meta-analysis. Hotopf data not used in meta-analysis to avoid duplication with Unwin
data. Gray study compares Gulf versus controls deployed elsewhere for meta-analysis.
742 H. V. Thomas et al.
depending on the severity of the illness. For
those studies that reported prevalence of severe
and moderate illness separately the estimates
were summed to provide one OR for each study.
Although Gulf deployment was strongly associ-
ated with chronic multi-symptom illness (OR
3.62, 95% CI 2.75–4.76), the test for hetero-
geneity between studies was highly statistically
signiﬁcant (p<0.001).
There were six studies which reported
prevalence of numbness or tingling sensations
(Proctor et al. 1998; Fukuda et al. 1998; Ishoy
et al. 1999; Unwin et al. 1999; Kang et al. 2000;
Cherry et al. 2001). Deployment to the Gulf
War was associated with a two-fold increase in
odds of reporting such sensations (OR 2.37,
95% CI 1.80–3.12). The variation in deﬁnition
of outcome and period of prevalence across
studies might have led to the statistically
signiﬁcant heterogeneity (x2=35.5, df=4,
p<0.001).
Only two studies reported the association
between Gulf deployment and ﬁbromyalgia.
The Iowa study (1997) reported a 1-month
prevalence of 18.2% amongst Gulf War regular
military veterans and a prevalence of 9.2%
amongst non-Gulf regular military veterans.
Goss Gilroy (1998) did not quote prevalence
ﬁgures, but reported an OR of 1.81 (95% CI
1.55–2.13) with respect to Gulf deployment.
DISCUSSION
This systematic review supports the hypothesis
that deployment to the Gulf War is associ-
ated with greater reporting of multi-symptom
Table 4. Studies that have investigated the association between deployment to the Gulf War
and multiple chemical sensitivity amongst veterans
First-named
author Outcome deﬁnition Prevalence
OR (95% CI) in
relation to Gulf
deployment
% weight in
meta-analysis
Bell, 1998 Consider self especially sensitive to
certain chemicals currently
GWV prevalence 62.5% 2.38 (0.67–8.49) 13.1
NGV prevalence 41.2%
Goss Gilroy,
1998
Report illness from chemical sensitivity,
o2 incitants,o2 organ system
symptoms, behaviour change
OR multiple chemical sensitivity
by Gulf deployment
4.01 (95% CI 2.43–6.62)
Unwin, 1999 Shortened version of Kipen et al.’s (1995)
measurement of symptoms of possible
chemical sensitivity
GWV prevalence 0.8%
Bosnia prevalence 0.4%
Era prevalence 0.3%
Reid, 2001 Symptoms reportedo3 organ sites
including CNS, durationo3 months,
sensitivity too4 substances from
shortened version of Kipen et al.’s
(1995) list
GWV prevalence 1.3% 6.89 (2.73–17.36) 19.3
Bosnia prevalence 0.3%
Era prevalence 0.2%
Black, 2000 Report illness from chemical sensitivity,
o2 incitants,o2 organ system
symptoms, impairment or behaviour
change
GWV prevalence 5.41% 2.19 (1.54–3.12) 35.0
NGV prevalence 2.55%
Proctor, 2001 >1 symptom that began after service,
o2 organ system symptoms,
symptoms triggered by low-level
chemical exposure, symptoms that
cannot be explained by any diagnosis
GWV prevalence 2.9% 2.91 (0.16–53.66) 3.4
Germany deployed prevalence 0%
Gray, 2002 Self-reported physician diagnosis of
multiple chemical sensitivity, onset
after Aug. 1991
GWV prevalence 1.62% 5.06 (2.91–8.77) 29.2
Deployed elsewhere
prevalence 0.32%
Non-deployed prevalence 0.39%
Summary OR 3.56 (2.03–6.24)
Heterogeneity x2=9.7, df=4, p=0.05
GWV, Gulf War veterans; NGV, non-Gulf veterans.
OR, Odds ratio with conﬁdence intervals in parentheses. Summary OR derived from random-eﬀects model.
Goss Gilroy data not used in meta-analysis since raw numbers not provided. Unwin data not used in meta-analysis to avoid duplication with
Reid data. Reid study compares Gulf versus era controls for meta-analysis. Gray study compares Gulf versus controls deployed elsewhere for
meta-analysis.
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conditions. Each of the primary studies consist-
ently demonstrated that a greater proportion
of Gulf war veterans than non-Gulf veterans
reported either a deﬁned multi-symptom con-
dition or individual symptoms of fatigue and
numbness. Gulf deployment was most strongly
associated with chronic fatigue, with Gulf War
veterans being almost four times more likely
than non-Gulf veterans to report such symp-
toms. The odds of reporting multiple chemical
sensitivity or chronic multi-symptom illness as
deﬁned by CDC were also approximately three
and a half times greater amongst Gulf War
veterans. The evidence for an association with
ﬁbromyalgia was limited to the results from
only two studies.
We used a random-eﬀects model in the
meta-analyses to estimate summary ORs.
This procedure estimates the mean of the dis-
tribution of possible eﬀect sizes. We also quote
a test for heterogeneity based on a ﬁxed-eﬀects
model. There is strong evidence that there is
not a single eﬀect size underlying the variation
in results of these studies. There are a number
of reasons why this should be so, including
variation in the case-deﬁnition used in the
diﬀerent studies as well as the diﬀerence in
sampling and between the nations. However,
all the studies reported an association between
Gulf deployment and multi-symptom con-
ditions so the heterogeneity arises from diﬀer-
ence in strength rather than direction of
association.
Irrespective of the relative risk, the prevalence
of chronic fatigue and multiple chemical sensi-
tivity amongst Gulf War veterans was relatively
low (maximum estimate approximately 7%).
The prevalence of CDC-deﬁned chronic multi-
symptom illness was much higher amongst Gulf
veterans, but was also reported in over 30% of
Table 5. Studies that have investigated the association between deployment to the Gulf War
and deﬁned ‘chronic multi-symptom illness ’ amongst veterans
First-named
author Outcome deﬁnition Prevalence
OR (95% CI) in
relation to Gulf
deployment
% weight in
meta-analysis
Fukuda, 1998 CDC Chronic multi-symptom illness :
o1 symptom (6 months) fromo2
of following: fatigue, mood and
cognition, musculoskeletal
Severe 4.76 (4.05–5.58) 24.8
GWV prevalence 6.0%
NGV prevalence 0.7%
Mild to moderate
GWV prevalence 39%
NGV prevalence 14%
Unwin, 1999 CDC Chronic multi-symptom illness :
o1 symptom (6 months) fromo2
of following: fatigue, mood and
cognition, musculoskeletal
GWV prevalence 61.9% 2.84 (2.54–3.16) 26.0
Bosnia prevalence 36.8%
Era prevalence 36.4%
Unwin, 2002 CDC Chronic multi-symptom illness GWV prevalence 63.8% 3.33 (2.23–4.96) 17.3
Bosnia prevalence 36.6%
Era prevalence 34.7%
Steele, 2000 CDC Chronic multi-symptom illness :
o1 symptom (6 months) fromo2
of cognition, musculoskeletal
GWV prevalence 47.2% 3.63 (2.81–4.68) 21.9
NGV prevalence 19.8%
Proctor, 2001 CDC Chronic multi-symptom illness :
o1 symptom (6 months) fromo2
of following: fatigue, mood and
cognition, musculoskeletal
GWV prevalence 65.3% 3.93 (1.98–7.83) 10.0
Germany deployed prevalence 32.6%
Severe
GWV prevalence 31.9%
NGV prevalence 4.4%
Mild to moderate
GWV prevalence 33.4%
NGV prevalence 28.3%
Summary OR 3.62 (2.75–4.76)
Heterogeneity x2=28.0, df=4, p<0.001
GWV, Gulf War veterans; NGV, non-Gulf veterans.
OR, Odds ratio with conﬁdence intervals in parentheses. Summary OR derived from random-eﬀects model.
Fukuda study sums prevalence of severe and mild-moderate symptoms for meta-analysis. Unwin study compares Gulf versus era controls
for meta-analysis. Proctor study sums prevalence of severe and mild-moderate symptoms for meta-analysis.
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veterans who had not been deployed to the Gulf
arena.
Limitations of primary studies
Sample size
The number of Gulf War veterans sampled
ranged from 24 (Bell et al. 1998) to over 23 000
(Simmons et al. 2004). This variation in sample
size can be seen in the diﬀerential weighting of
studies in the meta-analysis. Although a small
sample size might be a limitation of an indi-
vidual study, the possibility of a Type II error
occurring in this review is minimized by the
pooling of data from all appropriate studies to
increase statistical power.
Sample selection and response bias
In a cross-sectional survey it is important to
derive a random sample of all those subjects
who are potentially eligible in order to generate
a representative sample of the larger population
of interest. Those studies which selected a ran-
dom sample of veterans from either American,
British, Canadian or Danish military personnel
databases are likely to have fulﬁlled this cri-
terion. However, those studies which sampled
from individual military units are more prone
to selection bias (Sutker et al. 1993; Bell et al.
1998; Fukuda et al. 1998; Proctor et al. 1998,
2001; Gray et al. 1999).
Furthermore, once the sample has been
selected it is important to maintain its ability
to represent the larger population by achieving
a high response rate. In general, most of the
studies achieved a satisfactory response rate
of o70% amongst veterans of the Gulf War.
However the response rate amongst non-Gulf
veterans tended to be systematically lower in
most studies for which data were available.
Unwin et al. (1999) intensively followed up a
random selection of non-responders and found
that those with more symptoms responded
earlier, although mean SF-36 ratings of health
perception and ratings of physical function
did not diﬀer signiﬁcantly by response time.
There was no signiﬁcant interaction between
deployment, late response and health out-
come since Gulf War late responders did not
diﬀer from Bosnia or era late responders. So
the prevalence estimate of symptoms might be
a biased overestimate, but relative measures
of eﬀect, as reported here, should be less prone
to bias.
Measurement of health outcomes
All of the studies relied on the veterans’ self-
report of symptoms without any alternative
method of ascertainment. This is prone both to
random measurement error which would tend
to nullify any association between Gulf deploy-
ment and symptom reporting, and more import-
antly to measurement bias. All the symptoms
and, therefore, case-deﬁnitions rely upon self-
report and independent ascertainment is im-
possible. Gray et al. (2002) quoted a kappa
coeﬃcient of 0.6 indicating moderate reliability
of self-reported physician-diagnosed medical
conditions but reliability was poorer (kappa
x0.01 to 0.86) for self-reported symptoms in
139 subjects. It is noteworthy that only Sutker
et al. (1993) measured the prevalence of fatigue
symptoms soon after the veterans’ return from
the Gulf whereas the remainder of studies
measured symptoms after 1994, by which time
media interest in the health of Gulf War vet-
erans might have led to an increased awareness
and increased reporting of symptoms.
It is worth mentioning that the diagnostic
criteria for the multi-symptom conditions that
are included in this review remain controversial,
and indeed it has been suggested that these
‘functional somatic illnesses ’ might be variants
of one another (Wessely et al. 1999). Some
might argue that the similarity of ORs for the
multi-symptom conditions supports the idea
that they have a common aetiology. How-
ever, the controversial nature of these syn-
dromes should not aﬀect our conclusions as
the studies included in the review have used
the same case-deﬁnition when comparing Gulf
War Veterans with those not deployed to the
Gulf.
Confounding
The adjustment for confounders varied between
studies (see Table 1) but the later and larger
studies, which also contributed more to the
meta-analysis, tended to deal with this more
throughly. The studies of Goss Gilroy (1998),
Ishoy et al. (1999), Unwin et al. (1999) and
Cherry et al. (2001) used veterans matched on
age, sex and some aspect of military status.
An important confounder for these health
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outcomes would be symptom reporting before
deployment to the Gulf. Ishoy et al. (1999) and
White et al. (2001) asked veterans about symp-
toms with an onset after August 1990, but the
questionnaires were administered in the late
1990s so the responses are still open to recall
bias. Ishoy et al. (1999) reported that the preva-
lence of symptoms of fatigue with onset before
August 1990 was very similar amongst Gulf and
non-Gulf veterans and was much lower than
the prevalence of symptoms with onset after the
Gulf. This would suggest that the association
between Gulf deployment and symptoms of
fatigue is not confounded by baseline symptom
severity.
In general, adjustment for confounders in
these studies tended to reduce the strength of
association between Gulf deployment and
multi-symptom conditions. The results for the
meta-analysis are on unadjusted ﬁndings so
are likely to overestimate the association. On the
other hand, the idea that deployed troops were
healthier than their non-deployed counterparts
is also quite plausible, at least for the US army,
in which case the inability to adjust for this
might suggest that the reported ﬁndings are
underestimates.
Strengths and limitations of this review
This review beneﬁts from a highly sensitive
search strategy based on both published
material and on grey literature such as con-
ference abstracts and preliminary reports.
Inclusion and exclusion criteria were indepen-
dently assessed by two reviewers and in the case
of any disagreement the reference was included
until the next stage of data extraction to ensure
no references were excluded unnecessarily.
However, as in all systematic reviews, we may
have failed to identify some studies.
This review has been limited to investigating
associations between Gulf deployment versus
non-deployment and reporting of various
symptoms. We cannot oﬀer any insight into the
possible mechanisms underlying the observed
associations. It is also possible that an associ-
ation might exist between a speciﬁc environ-
mental exposure (e.g. threat of chemical warfare
agents, pyridostigmine bromide, petrochemicals,
non-routine immunizations) and reporting of
symptoms. We chose not to examine these
associations in this review due to the problems
associated with the inaccuracy of such self-
reported exposures.
CONCLUSION
We identiﬁed 23 references that compared the
prevalence of multi-symptom conditions in both
Gulf War veterans and non-Gulf veterans. The
results support the hypothesis that deployment
to the Gulf War is associated with greater
reporting of multi-symptom conditions. Gulf
deployment was most strongly associated with
chronic fatigue, with Gulf War veterans being
almost four times more likely than non-Gulf
veterans to report such symptoms. However it
seems likely that at least some of this association
might be explained by response bias, measure-
ment bias and confounding. This review cannot
shed light on any biological or socio-cultural
mechanisms underlying this association but
adds to the increasing body of evidence that
suggests veterans of military deployment are
more likely to subsequently report a variety of
poorly understood complaints including fatigue,
pain and associated symptoms.
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